Send us Feedback

Antigenics (AGEN)
Analysis
Data
Financials
No Sales Breakout Data.
Balance Sheet    (USD)
Annual | Quarterly
QUARTER ENDING older 30-SEP
2008		 31-DEC
2008		 31-MAR
2009		 30-JUN
2009		 30-SEP
2009		 newer
Cash & Equivalents 30.9M 24.5M 14.6M 16.1M 29.0M
Short Term Investments 9.95M 9.99M 9.99M 5.00M 5.00M
Accounts Receivable 0 0 0 443K 325K
Inventories 226K 226K 226K 217K 24K
Pre-paid Expenses 870K 610K 1.05M 1.02M 915K
Deferred Tax Assets 0 0 0 0 0
Other Current Assets 379K 187K 529K 534K 694K
Total Current Assets 42.3M 35.5M 26.4M 23.3M 36.0M
Property, Plant & Equipment 12.3M 11.5M 10.8M 10.1M 9.43M
Goodwill & Intangibles 5.28M 5.00M 4.72M 4.45M 4.17M
Other Long-term Assets 2.62M 4.92M 4.76M 1.84M 1.78M
Total Long-Term Assets 20.2M 21.5M 20.3M 16.4M 15.4M
Total Assets 62.5M 56.9M 46.7M 39.7M 51.4M
Accounts Payable 699K 541K 590K 717K 661K
Accrued Expenses 0 0 0 0 0
Short Term Debt 146K 146K 146K 146K 146K
Other Current Liabilities 1.56M 1.69M 1.62M 2.23M 2.11M
Total Current Liabilities 9.08M 7.00M 6.06M 6.64M 6.19M
Long Term Debt 78.5M 67.8M 63.2M 48.9M 48.0M
Capital Lease Obligations 0 0 0 0 0
Deferred Income Tax 0 0 0 0 0
Other Long-term Liabilities 4.82M 6.03M 8.19M 12.8M 16.1M
Total Long-term Liabilities 83.3M 73.9M 71.3M 61.6M 64.1M
Minority Interest 0 0 0 0 0
Total Liabilities 92.4M 80.9M 77.4M 68.3M 70.3M
Preferred Stock 369 0 0 0 0
Common Par 664K 665K 671K 785K 900K
Additional Paid-In Capital 502M 503M 511M 525M 545M
Retained Earnings -533M -527M -542M -554M -564M
Treasury Stock -270K -270K -325K -325K -325K
Other Equity 0 1K 0 0 1K
Total Shareholder's Equity -29.9M -23.9M -30.7M -28.6M -18.9M
 
 
 
 
 
Data Sources:
Market and financial statement data provided by NASDAQ, BATS Exchange, SEC and Xignite Inc. Industry and operating metrics collected from company filings via EDGAR online. For more information on sources and calculations click here.
Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki